Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations
Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent...
Gespeichert in:
Veröffentlicht in: | International journal of medical sciences 2019-01, Vol.16 (3), p.450-460 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 460 |
---|---|
container_issue | 3 |
container_start_page | 450 |
container_title | International journal of medical sciences |
container_volume | 16 |
creator | Abdullah, Mardiaty Iryani Junit, Sarni Mat Ng, Khoon Leong Jayapalan, Jaime Jacqueline Karikalan, Barani Hashim, Onn Haji |
description | Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations. |
doi_str_mv | 10.7150/ijms.29935 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6428975</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2197900345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-9d8e66705c3d80f4a972ad186de7a4d8841e0f0e55e2d87f4985cfe62024ac63</originalsourceid><addsrcrecordid>eNpVkVFPwjAUhRujEURf_AFmj8YEbLtuXX0wQaJIgtGHvTe1vYPiWLHdSPj3DkGCT7fJ_Xp6eg5C1wQPOEnwvV0sw4AKEScnqEsYE30iMD89OnfQRQgLjGMac3KOOjEWhFAuuij_UCtblspvony-8c6aaKQqDf4hGkMFtdXRsKzBq9q6KkSqMtGbK0E37ZXoybql8l_go0m1hlDb2Q67RGeFKgNc7WcP5S_P-ei1P30fT0bDaV8zxuq-MBmkKceJjk2GC6YEp8qQLDXAFTNZxgjgAkOSADUZL5jIEl1ASjFlSqdxDz3uZFfN5xKMhqr2qpQrb1tXG-mUlf83lZ3LmVvLlNFM8KQVuN0LePfdtB-QSxs0tHFU4JogKRFctKmxLXq3Q7V3IXgoDs8QLLctyG0L8reFFr45NnZA_2KPfwBgboU2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2197900345</pqid></control><display><type>article</type><title>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Abdullah, Mardiaty Iryani ; Junit, Sarni Mat ; Ng, Khoon Leong ; Jayapalan, Jaime Jacqueline ; Karikalan, Barani ; Hashim, Onn Haji</creator><creatorcontrib>Abdullah, Mardiaty Iryani ; Junit, Sarni Mat ; Ng, Khoon Leong ; Jayapalan, Jaime Jacqueline ; Karikalan, Barani ; Hashim, Onn Haji</creatorcontrib><description>Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.</description><identifier>ISSN: 1449-1907</identifier><identifier>EISSN: 1449-1907</identifier><identifier>DOI: 10.7150/ijms.29935</identifier><identifier>PMID: 30911279</identifier><language>eng</language><publisher>Australia: Ivyspring International Publisher</publisher><subject>Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Female ; Goiter, Nodular - complications ; Humans ; Male ; MicroRNAs ; Neoplasm Recurrence, Local - genetics ; Proteomics ; Proto-Oncogene Proteins B-raf - genetics ; Proto-Oncogene Proteins c-ret - genetics ; ras Proteins - genetics ; Review ; Thyroid Cancer, Papillary - diagnosis ; Thyroid Cancer, Papillary - genetics ; Thyroid Cancer, Papillary - therapy ; Thyroid Neoplasms - diagnosis ; Thyroid Neoplasms - genetics ; Thyroid Neoplasms - therapy</subject><ispartof>International journal of medical sciences, 2019-01, Vol.16 (3), p.450-460</ispartof><rights>Ivyspring International Publisher 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-9d8e66705c3d80f4a972ad186de7a4d8841e0f0e55e2d87f4985cfe62024ac63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428975/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428975/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30911279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abdullah, Mardiaty Iryani</creatorcontrib><creatorcontrib>Junit, Sarni Mat</creatorcontrib><creatorcontrib>Ng, Khoon Leong</creatorcontrib><creatorcontrib>Jayapalan, Jaime Jacqueline</creatorcontrib><creatorcontrib>Karikalan, Barani</creatorcontrib><creatorcontrib>Hashim, Onn Haji</creatorcontrib><title>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</title><title>International journal of medical sciences</title><addtitle>Int J Med Sci</addtitle><description>Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.</description><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Female</subject><subject>Goiter, Nodular - complications</subject><subject>Humans</subject><subject>Male</subject><subject>MicroRNAs</subject><subject>Neoplasm Recurrence, Local - genetics</subject><subject>Proteomics</subject><subject>Proto-Oncogene Proteins B-raf - genetics</subject><subject>Proto-Oncogene Proteins c-ret - genetics</subject><subject>ras Proteins - genetics</subject><subject>Review</subject><subject>Thyroid Cancer, Papillary - diagnosis</subject><subject>Thyroid Cancer, Papillary - genetics</subject><subject>Thyroid Cancer, Papillary - therapy</subject><subject>Thyroid Neoplasms - diagnosis</subject><subject>Thyroid Neoplasms - genetics</subject><subject>Thyroid Neoplasms - therapy</subject><issn>1449-1907</issn><issn>1449-1907</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkVFPwjAUhRujEURf_AFmj8YEbLtuXX0wQaJIgtGHvTe1vYPiWLHdSPj3DkGCT7fJ_Xp6eg5C1wQPOEnwvV0sw4AKEScnqEsYE30iMD89OnfQRQgLjGMac3KOOjEWhFAuuij_UCtblspvony-8c6aaKQqDf4hGkMFtdXRsKzBq9q6KkSqMtGbK0E37ZXoybql8l_go0m1hlDb2Q67RGeFKgNc7WcP5S_P-ei1P30fT0bDaV8zxuq-MBmkKceJjk2GC6YEp8qQLDXAFTNZxgjgAkOSADUZL5jIEl1ASjFlSqdxDz3uZFfN5xKMhqr2qpQrb1tXG-mUlf83lZ3LmVvLlNFM8KQVuN0LePfdtB-QSxs0tHFU4JogKRFctKmxLXq3Q7V3IXgoDs8QLLctyG0L8reFFr45NnZA_2KPfwBgboU2</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Abdullah, Mardiaty Iryani</creator><creator>Junit, Sarni Mat</creator><creator>Ng, Khoon Leong</creator><creator>Jayapalan, Jaime Jacqueline</creator><creator>Karikalan, Barani</creator><creator>Hashim, Onn Haji</creator><general>Ivyspring International Publisher</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190101</creationdate><title>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</title><author>Abdullah, Mardiaty Iryani ; Junit, Sarni Mat ; Ng, Khoon Leong ; Jayapalan, Jaime Jacqueline ; Karikalan, Barani ; Hashim, Onn Haji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-9d8e66705c3d80f4a972ad186de7a4d8841e0f0e55e2d87f4985cfe62024ac63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Female</topic><topic>Goiter, Nodular - complications</topic><topic>Humans</topic><topic>Male</topic><topic>MicroRNAs</topic><topic>Neoplasm Recurrence, Local - genetics</topic><topic>Proteomics</topic><topic>Proto-Oncogene Proteins B-raf - genetics</topic><topic>Proto-Oncogene Proteins c-ret - genetics</topic><topic>ras Proteins - genetics</topic><topic>Review</topic><topic>Thyroid Cancer, Papillary - diagnosis</topic><topic>Thyroid Cancer, Papillary - genetics</topic><topic>Thyroid Cancer, Papillary - therapy</topic><topic>Thyroid Neoplasms - diagnosis</topic><topic>Thyroid Neoplasms - genetics</topic><topic>Thyroid Neoplasms - therapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Abdullah, Mardiaty Iryani</creatorcontrib><creatorcontrib>Junit, Sarni Mat</creatorcontrib><creatorcontrib>Ng, Khoon Leong</creatorcontrib><creatorcontrib>Jayapalan, Jaime Jacqueline</creatorcontrib><creatorcontrib>Karikalan, Barani</creatorcontrib><creatorcontrib>Hashim, Onn Haji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of medical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdullah, Mardiaty Iryani</au><au>Junit, Sarni Mat</au><au>Ng, Khoon Leong</au><au>Jayapalan, Jaime Jacqueline</au><au>Karikalan, Barani</au><au>Hashim, Onn Haji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations</atitle><jtitle>International journal of medical sciences</jtitle><addtitle>Int J Med Sci</addtitle><date>2019-01-01</date><risdate>2019</risdate><volume>16</volume><issue>3</issue><spage>450</spage><epage>460</epage><pages>450-460</pages><issn>1449-1907</issn><eissn>1449-1907</eissn><abstract>Papillary thyroid cancer (PTC) is the most prevalent form of malignancy among all cancers of the thyroid. It is also one of the few cancers with a rapidly increasing incidence. PTC is usually contained within the thyroid gland and generally biologically indolent. Prognosis of the cancer is excellent, with less than 2% mortality at 5 years. However, more than 25% of patients with PTC developed a recurrence during a long term follow-up. The present article provides an updated condensed overview of PTC, which focuses mainly on the molecular alterations involved and recent biomarker investigations.</abstract><cop>Australia</cop><pub>Ivyspring International Publisher</pub><pmid>30911279</pmid><doi>10.7150/ijms.29935</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1449-1907 |
ispartof | International journal of medical sciences, 2019-01, Vol.16 (3), p.450-460 |
issn | 1449-1907 1449-1907 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6428975 |
source | MEDLINE; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Female Goiter, Nodular - complications Humans Male MicroRNAs Neoplasm Recurrence, Local - genetics Proteomics Proto-Oncogene Proteins B-raf - genetics Proto-Oncogene Proteins c-ret - genetics ras Proteins - genetics Review Thyroid Cancer, Papillary - diagnosis Thyroid Cancer, Papillary - genetics Thyroid Cancer, Papillary - therapy Thyroid Neoplasms - diagnosis Thyroid Neoplasms - genetics Thyroid Neoplasms - therapy |
title | Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A07%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Papillary%20Thyroid%20Cancer:%20Genetic%20Alterations%20and%20Molecular%20Biomarker%20Investigations&rft.jtitle=International%20journal%20of%20medical%20sciences&rft.au=Abdullah,%20Mardiaty%20Iryani&rft.date=2019-01-01&rft.volume=16&rft.issue=3&rft.spage=450&rft.epage=460&rft.pages=450-460&rft.issn=1449-1907&rft.eissn=1449-1907&rft_id=info:doi/10.7150/ijms.29935&rft_dat=%3Cproquest_pubme%3E2197900345%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2197900345&rft_id=info:pmid/30911279&rfr_iscdi=true |